Health Care

A Washington, D.C.-based watchdog group is the latest to sue Zoom Video Communications over allegedly false privacy protection claims, saying the company misled and deceived users, such as those in the health care industry, who expected that the technology's encryption would protect their personal information, according to a lawsuit announced Tuesday. 

Unlike every other state with major outbreaks, New York only counts residents who died on nursing home property and not those who were transported to hospitals and died there.

Russia on Tuesday became the first country to clear a coronavirus vaccine and declare it ready for use, despite international skepticism. President Vladimir Putin said that one of his daughters has already been inoculated.

Gilead Sciences Inc said on Monday it has filed a marketing application with the U.S. Food and Drug Administration for its experimental COVID-19 drug remdesivir.

The recall, issued by Thomson on Aug. 1, includes red, yellow, white and sweet yellow onions which were shipped beginning May 1 in cartons weighing between five and 50 pounds, and mesh sacks between two and 50 pounds.

Amid the dual public health crises of COVID-19 and racism, some in the medical community are prescribing a somewhat nontraditional remedy: voting. Hospitals, doctors and healthcare institutions across the country are committing to efforts to engage Americans in the election process as part of Civic Health Month.

The president recently took action to lower the cost of prescription drugs.

An Indian yoga televangelist, who is an ally of Prime Minister Narendra Modi, claims to have already found the cure for the new coronavirus -- and it's for sale. 

Gilead Sciences said on Thursday that the drug company has gone into hyperdrive creating the antiviral drug remdesivir, the first treatment shown to be effective against COVID-19.

The eye-care unit, known as Bausch & Lomb, had $3.7 billion in revenue last year, compared with about $4.9 billion from the rest of the company.

Gilead will charge U.S. hospitals $3,120 for the average patient with commercial insurance.

The company's SARS-CoV-2 investigational vaccine, Ad26.COV2.S, will be provided at a "global not-for-profit basis for emergency pandemic use," the pharmaceutical giant said.

Moderna says orders for the experimental COVID vaccine are rolling in.

Clorox, the world's biggest cleaning products maker, said grocery store shelves won’t be fully stocked with the company's disinfecting wipes until next year, according to a report on Tuesday.

U.S. prosecutors are pursuing possible penalties of nearly $13 billion to resolve investigations of OxyContin maker Purdue Pharma.

After the U.S. government reportedly spent nearly $230 million to pay for COVID-19 test sites around the country, one small Texas company ended up establishing hundreds of testing stations, while bringing in more than $90 million in federal contracts.

Anti-abortion centers received at least $4 million in forgivable federal loans when the government issued its first coronavirus bailout, a report said Monday.

Lilly is already testing the drug in hospitals to study whether it can work as a treatment in patients who have the disease.

Under the agreed transaction, Siemens Healthineers will acquire all shares in Varian for $177.50 each in cash, representing a 24% premium to the U.S. company’s closing price on Friday.

Wait times for coronavirus test results have come down since the pandemic began, but there are still 10-14 day waits in many parts of the country, inhibiting America’s ability to flatten the curve. Now, pharmacists are pushing for the government to slash the red tape that stops them from being providers with the flexibility to test patients for coronavirus.